Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
Andrew X. Zhu, Jeffrey A. Meyerhardt, Lawrence S. Blaszkowsky, Avinash R. Kambadakone, Alona Muzikansky, Hui Zheng, Jeffrey W. Clark, Thomas A. Abrams, Jennifer A. Chan, Peter C. Enzinger, Pankaj Bhargava, Eunice L. Kwak, Jill N. Allen, Sanjay R. Jain, Keith Stuart, Kerry Horgan, Susan Sheehan, Charles S. Fuchs, David P. Ryan, Dushyant V. Sahani
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study'. Together they form a unique fingerprint.